Company Imexpharm Corporation

IMP

VN000000IMP0

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Ratings for Imexpharm Corporation

EPS Revisions

Annual profits - Rate of surprise

Sector Other Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. Other stock markets 06:00:00 2024-07-11 pm EDT			5-day change	1st Jan Change
81,600 ^VND	+4.35%		+19.68%	+58.59%

May. 27	Imexpharm Corporation Appoints Tnrong Minh Hung, A Non-Executive Member of the Board of Directors, as A Member of the Audit Committee Under the Board of Directors	CI
Apr. 19	Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Imexpharm Corporation is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. It is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.

Number of employees: 1,411

VND in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical 100.0 %	1,676,312	100.0 %	1,994,037	100.0 %	+18.95%

VND in Million	2022	Weight	2023	Weight	Delta
Vietnam 100.0 %	1,643,707	100.0 %	1,994,037	100.0 %	+21.31%

Managers	Title	Age	Since
Dao Thi Tran CEO	Chief Executive Officer	72	83-12-31
Tuan Minh Ngo COO	Chief Operating Officer	45	03-12-31
Kim Le Thi Nguyen SEC	Corporate Secretary	41	08-09-30
Hanh Hoai Tran AUD	Comptroller/Controller/Auditor	61	97-06-30
Nhung Van Huynh PRN	Corporate Officer/Principal	51	98-07-31

Members of the board	Title	Age	Since
Dao Thi Tran CEO	Chief Executive Officer	72	83-12-31
Nhung Van Huynh PRN	Corporate Officer/Principal	51	98-07-31
Tuan Minh Ngo COO	Chief Operating Officer	45	03-12-31
Khanh Vinh Thi Han BRD	Director/Board Member	48	18-04-27
Hung Minh Truong BRD	Director/Board Member	-	20-05-29

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	70,041,829	1,789,024 ( 2.554 %)	0	2.554 %

Name	Equities	%	Valuation
SK INC. 47.70 %	33,389,946	47.70 %	99 M ₫
Viet Nam Pharmaceutical Corp. 22.04 %	15,431,360	22.04 %	46 M ₫
Sunrise Kim Investment JSC 9.757 %	6,830,357	9.757 %	20 M ₫
Dao Thi Tran 0.5250 %	367,500	0.5250 %	1 M ₫
Dinh Quoc Nguyen 0.4500 %	315,000	0.4500 %	931 820 ₫
Tuan Minh Ngo 0.2250 %	157,500	0.2250 %	465 910 ₫
Nha Phuong Van Le 0.1635 %	114,450	0.1635 %	338 561 ₫
Nhung Van Huynh 0.1400 %	98,000	0.1400 %	289 900 ₫
Capital Asset Management Co., Ltd. 0.0336 %	23,520	0.0336 %	69 576 ₫

Imexpharm Corp.

No. 4, 30/4 Street, Ward 1

87000, Cao Lanh

http://www.imexpharm.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

81,600 VND

Average target price

68,848 VND

Spread / Average Target

-15.63%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
IMEXPHARM CORPORATION	+58.59%	237M
ELI LILLY AND COMPANY	+62.66%	841B
NOVO NORDISK A/S	+40.42%	625B
JOHNSON & JOHNSON	-4.37%	360B
MERCK & CO., INC.	+17.16%	327B
ABBVIE INC.	+9.87%	300B
ASTRAZENECA PLC	+15.66%	242B
NOVARTIS AG	+17.90%	227B
AMGEN INC.	+14.86%	174B
PFIZER, INC.	+0.45%	162B

Other Pharmaceuticals